Rankings
▼
Calendar
ZTS
Zoetis Inc.
$52B
Q2 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.3B
+5.0% YoY
Gross Profit
$807M
63.6% margin
Operating Income
$383M
30.2% margin
Net Income
$247M
19.5% margin
EPS (Diluted)
$0.50
QoQ Revenue Growth
+3.1%
Cash Flow
Operating Cash Flow
$180M
Free Cash Flow
$129M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$7.8B
Total Liabilities
$6.1B
Stockholders' Equity
$1.7B
Cash & Equivalents
$705M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.2B
+5.0%
Gross Profit
$807M
$809M
-0.2%
Operating Income
$383M
$356M
+7.6%
Net Income
$247M
$224M
+10.3%
Revenue Segments
Dogs and Cats
$533M
42%
Cattle
$382M
30%
Swine
$148M
12%
Poultry
$122M
10%
Horses
$35M
3%
Fish
$19M
2%
Sheep and Other
$18M
1%
← FY 2017
All Quarters
Q3 2017 →
ZTS Q2 2017 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena